Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Proponents often stress the opportunity for substantial therapeutic outcomes, especially in diseases where conventional treatments have proven inadequate. However, crucially important to assess the significant financial expenditure associated with CPI